These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 12475827

  • 1. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
    Gupta NC, Rogers JS, Graeber GM, Gregory JL, Waheed U, Mullet D, Atkins M.
    Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
    [Abstract] [Full Text] [Related]

  • 2. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
    Sun Y, Yu H, Ma J, Lu P.
    PLoS One; 2016 Dec; 11(8):e0161764. PubMed ID: 27560933
    [Abstract] [Full Text] [Related]

  • 3. FDG PET of pleural effusions in patients with non-small cell lung cancer.
    Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF.
    AJR Am J Roentgenol; 2000 Jul; 175(1):245-9. PubMed ID: 10882281
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS, Kim IJ, Kim SJ, Pak K, Kim K.
    Onkologie; 2011 Jul; 34(6):298-303. PubMed ID: 21625182
    [Abstract] [Full Text] [Related]

  • 5. [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
    Liao R, Yang X, Wang S, Zhou Q, Nie Q, Zhong W, Dong S, Wu Y.
    Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):652-5. PubMed ID: 23164351
    [Abstract] [Full Text] [Related]

  • 6. [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
    Buchmann I, Guhlmann CA, Elsner K, Gfrörer W, Schirrmeister H, Kotzerke J, Buck A, Reske SN.
    Nuklearmedizin; 1999 Nov; 38(8):319-22. PubMed ID: 10615665
    [Abstract] [Full Text] [Related]

  • 7. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
    Yang MF, Tong ZH, Wang Z, Zhang YY, Xu LL, Wang XJ, Li W, Wu XZ, Wang W, Zhang YH, Jiang T, Shi HZ.
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
    [Abstract] [Full Text] [Related]

  • 8. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, Erginel S.
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [Abstract] [Full Text] [Related]

  • 9. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.
    Schaffler GJ, Wolf G, Schoellnast H, Groell R, Maier A, Smolle-Jüttner FM, Woltsche M, Fasching G, Nicoletti R, Aigner RM.
    Radiology; 2004 Jun; 231(3):858-65. PubMed ID: 15105451
    [Abstract] [Full Text] [Related]

  • 10. Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis.
    Fjaellegaard K, Koefod Petersen J, Reuter S, Malene Fischer B, Gerke O, Porcel JM, Frost Clementsen P, Laursen CB, Bhatnagar R, Bodtger U.
    Lung Cancer; 2021 Dec; 162():106-118. PubMed ID: 34775214
    [Abstract] [Full Text] [Related]

  • 11. Atypical Layering of FDG in Pleural Effusion.
    Han EJ, Yoon H, Choi WH.
    Clin Nucl Med; 2024 Feb 01; 49(2):162-165. PubMed ID: 37976534
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
    Duysinx B, Nguyen D, Louis R, Cataldo D, Belhocine T, Bartsch P, Bury T.
    Chest; 2004 Feb 01; 125(2):489-93. PubMed ID: 14769729
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.
    Nakajima R, Abe K, Sakai S.
    Medicine (Baltimore); 2015 Jul 01; 94(29):e1010. PubMed ID: 26200610
    [Abstract] [Full Text] [Related]

  • 14. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
    Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A.
    Chest; 1998 Sep 01; 114(3):713-22. PubMed ID: 9743156
    [Abstract] [Full Text] [Related]

  • 15. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
    Kwek BH, Aquino SL, Fischman AJ.
    Chest; 2004 Jun 01; 125(6):2356-60. PubMed ID: 15189963
    [Abstract] [Full Text] [Related]

  • 16. A PET-CT score for discriminating malignant from benign pleural effusions.
    Simó M, Persiva O, Sánchez L, Montoro B, Vázquez A, Sansano I, Alemán C.
    Med Clin (Barc); 2023 Nov 24; 161(10):422-428. PubMed ID: 37487808
    [Abstract] [Full Text] [Related]

  • 17. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
    Graeber GM, Gupta NC, Murray GF.
    J Thorac Cardiovasc Surg; 1999 Apr 24; 117(4):719-27. PubMed ID: 10096967
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Bertagna F, Prior JO, Ceriani L, Giovanella L.
    Acad Radiol; 2014 Jan 24; 21(1):11-20. PubMed ID: 24331260
    [Abstract] [Full Text] [Related]

  • 19. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 24; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 20. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
    Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ.
    Eur J Cardiothorac Surg; 1999 Sep 24; 16 Suppl 1():S25-30. PubMed ID: 10536941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.